Associate Director / Director, Patient Marketing

Bothell, WA (On-site)

$183K/yr – $230K/yrDirector/Executive7+ years expFull time

Posted 4 months ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Own the end-to-end patient marketing strategy and digital ecosystem for desmoid tumor programs, driving patient education, activation, and adherence across lifecycle.

  • Must-have: 7+ years in pharma/biotech patient marketing with oncology launch
  • Standout: Deep experience shaping patient messaging with patient services and advocacy collaboration
  • Standout: Hands-on digital channel expertise (web, social, CRM, paid media) and experience with MLR/PRC processes

Job Description

Responsibilities

  • Patient Strategy
  • Develop and execute a comprehensive U.S. patient marketing strategy across the product lifecycle, including unbranded disease awareness and branded campaigns
  • Maintain and continuously refine the patient journey by identifying new inflection points, emotional hurdles, and barriers to treatment through ongoing insights collection
  • Lead patient-focused market research, in collaboration with the market insights team, to ensure all brand messaging resonates with the lived experience of patients with desmoid tumors
  • Resource and Digital Ecosystem Development
  • Lead the creation of all patient-facing materials (i.e., patient discussion guide, patient starter kit) and partner closely with the HCP Marketing Lead to ensure patient resources are effectively utilized by the field in the clinical setting
  • Design and implement an integrated digital ecosystem (e.g., branded patient websites, paid search, social, CRM, programmatic) that supports education, activation, and treatment adherence
  • Establish foundational metrics/KPIs and optimize performance in real-time
  • Leadership and Collaboration
  • Lead the internal integration of patient insights across the organization, partnering with cross-functional teams to bridge the gap between clinical data and patient experience, ensuring a seamless and unified brand journey
  • Partner with patient services and market access teams to build messaging and support tools that address affordability, reimbursement, and treatment continuity

Requirements

  • Bachelor’s degree required; Advanced degree (e.g., PharmD, MBA) preferred
  • Oncology launch experience required
  • 7+ years of experience in pharmaceutical, biotech, or healthcare marketing, with a strong focus on patient marketing
  • Proven success in digital patient marketing (web, social, SEO/SEM, CRM, and paid media strategy) and media planning and execution
  • Deep understanding of the patient journey and emotional drivers of behavior in rare oncology disease populations
  • Experience collaborating with patient services (patient advocacy and PSP) to develop aligned messaging and support tools
  • Demonstrated ability to thrive in a fast-paced biotech environment
  • Ability to travel ≥20%, including occasional weekends
  • Knowledge and Skills
  • Strong analytical and problem-solving skills, with the ability to leverage market research and performance data to inform decisions and optimize impact
  • Strong project management and operational execution skills; able to manage multiple workstreams and launch-critical deadlines in a fast-paced environment
  • Excellent communication, storytelling, and presentation skills—able to simplify complex clinical information for varied audiences
  • Experience managing agencies/vendors, budgets, and complex project plans with strong operational rigor and attention to detail
  • Strong understanding of MLR/PRC processes, claims substantiation, and OPDP regulations
  • Strong cross-functional leadership skills, including the ability to influence without authority

Preferred

  • Advanced degree (e.g., PharmD, MBA) preferred
  • Experience in oncology launch
Immunome, Inc. logo

Immunome, Inc.

2.5 Glassdoor

Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted therapies designed to improve outcomes for cancer patients. We are advancing an innovative portfolio of therapeutics, drawing on leadership that previously played key roles in the design, development, and commercialization of cutting-edge targeted cancer therapies, including antibody-drug conjugate therapies (ADCs). Our most advanced pipeline programs are varegacestat (formerly AL102), a gamma secretase inhibitor which is currently in a Phase 3 trial for treatment of desmoid tumors; IM-1021, a ROR1-targeted ADC which is currently in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand, which recently received IND clearance. Our pipeline also includes IM-1617, IM-1335, and IM-1340, all of which are preclinical ADCs pursuing undisclosed targets with expression in multiple solid tumors.

Founded in 2008
Bothell, Washington, USA
187 employees (3 in marketing)
58% recommend to a friend

Traffic Signals

Monthly Visitors
12.4K
Traffic Source Mix
Search
31.1%
Direct
45.6%
Referral
6.5%
Social
15.2%
Paid
1.5%

Headcount Trend

Current headcount: ~191

Marketing Team

Marketing Team Size
3 (2% of company)

Funding

Total Funding
$998.9M
Last Raise
$400M
Post IPO Equity, 3 months ago

Funding History

  • Dec 2025
    Post IPO Equity • $400M
  • Jan 2025
    Post IPO Equity • $150M
  • Feb 2024
    Post IPO Equity • $230M

Recent News